Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- CBGJ398XUS04Independent statistical analysis of BGJ398 for Patients With Tumors With FGFR Genetic Alterations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02160041).
- CC-5013 (Lenalidomide) and Rituximab in Waldenstrom’s Macroglobulinemia: Complete Statistical AnalysisIndependent statistical analysis of CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142168).
- CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques: Complete Statistical AnalysisIndependent statistical analysis of CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CCN005BIndependent statistical analysis of Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males:…
- CCODAPPIndependent statistical analysis of Collaborative Care for Opioid Dependence And Pain Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04121546).
- CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements: Complete Statistical AnalysisIndependent statistical analysis of CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CCRFastIndependent statistical analysis of Comprehensive Cardiac Rehabilitation Feasibility After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03944668).
- CCT_DEVIndependent statistical analysis of Computerized Cognitive Training for Diabetic Elderly Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01736124).
- CDIndependent statistical analysis of Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy: Complete Statistical AnalysisIndependent statistical analysis of CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CD2 SCDIndependent statistical analysis of Siplizumab for Sickle Cell Disease Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06078696).
- CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR: Complete Statistical AnalysisIndependent statistical analysis of CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR: primary endpoint results, effect estimate with confidence interval,…
- CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- CDP-Choline and Working Memory After TBI: A Neuroimaging Study: Complete Statistical AnalysisIndependent statistical analysis of CDP-Choline and Working Memory After TBI: A Neuroimaging Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00727246).
- CEASEIndependent statistical analysis of Crohn Disease Exclusion Diet After Single Medication De-escalation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02472457).
- Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers: Complete Statistical AnalysisIndependent statistical analysis of Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Cefprozil for Oral Suspension 250 mg/5 mL, Fasting: Complete Statistical AnalysisIndependent statistical analysis of Cefprozil for Oral Suspension 250 mg/5 mL, Fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835614).
- Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting: Complete Statistical AnalysisIndependent statistical analysis of Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835354).
- CELESTIALIndependent statistical analysis of the phase 3 CELESTIAL trial of cabozantinib versus placebo in hepatocellular carcinoma after prior sorafenib, including overall survival, progression-free survival, objective response, trial design, and statistical methodology.
- CELESTIALIndependent statistical analysis of Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Cell Phone Support to Promote Medication Adherence Among Adolescents and Young Adults With Chronic Illness: Complete Statistical AnalysisIndependent statistical analysis of Cell Phone Support to Promote Medication Adherence Among Adolescents and Young Adults With Chronic Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- CELLOIndependent statistical analysis of CELLO - CLiRpath® Excimer Laser System to Enlarge Lumen Openings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00595959).
- CENTAURIndependent statistical analysis of Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CERAIndependent statistical analysis of Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cerebellar Transcranial Direct Current Stimulation and Aphasia Treatment: Complete Statistical AnalysisIndependent statistical analysis of Cerebellar Transcranial Direct Current Stimulation and Aphasia Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02901574).
- Cerebral Autoregulation Monitoring During Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Cerebral Autoregulation Monitoring During Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00981474).
- Cerebral Blood Flow During Propofol Anaesthesia: Complete Statistical AnalysisIndependent statistical analysis of Cerebral Blood Flow During Propofol Anaesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02951273).
- Cerebral Blood Perfusion Changes After General Anesthesia for Craniotomy: Complete Statistical AnalysisIndependent statistical analysis of Cerebral Blood Perfusion Changes After General Anesthesia for Craniotomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01642147).
- Cerebral Protection in Transcatheter Aortic Valve Replacement: Complete Statistical AnalysisIndependent statistical analysis of Cerebral Protection in Transcatheter Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02214277).
- Cerebrospinal Fluid (CSF) Pharmacokinetics of Antimicrobials in Children: Complete Statistical AnalysisIndependent statistical analysis of Cerebrospinal Fluid (CSF) Pharmacokinetics of Antimicrobials in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00991185).
- CERPIndependent statistical analysis of RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the…
- Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis: Complete Statistical AnalysisIndependent statistical analysis of Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01087762).
- CERU-1401Independent statistical analysis of Predict Fluid Responsiveness in Spinal Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02070276).
- Cervical Cancer Prevention for Black Adults: Complete Statistical AnalysisIndependent statistical analysis of Cervical Cancer Prevention for Black Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04927494).
- Cervical Pessary to Prevent Preterm Birth in Singleton Pregnancies With a Sonographically Measured Short Cervix: Complete Statistical AnalysisIndependent statistical analysis of Cervical Pessary to Prevent Preterm Birth in Singleton Pregnancies With a Sonographically Measured Short Cervix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon: Complete Statistical AnalysisIndependent statistical analysis of Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cervical Spondylotic Myelopathy Surgical Trial: Complete Statistical AnalysisIndependent statistical analysis of Cervical Spondylotic Myelopathy Surgical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02076113).
- CESIndependent statistical analysis of The Effects of Cranial Electrotherapy Stimulation (CES) on Brain Function, Brain Chemistry and Mood: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CES1 Carriers in the PAPI Study: Complete Statistical AnalysisIndependent statistical analysis of CES1 Carriers in the PAPI Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03188705).
- CetaphilIndependent statistical analysis of Healing Ointment Usage Post-surgical Procedure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05686928).
- Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02589392).
- Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01388790).
- CEUS For Intraoperative Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of CEUS For Intraoperative Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05530798).
- CG400549Independent statistical analysis of Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- CGDNIndependent statistical analysis of N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265563).